[4-[8-amino-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methanol;1-(1-benzothiophen-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1,3-benzoxazol-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(5-fluoro-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-inden-5-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-indol-6-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-indol-6-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(5-methyl-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine

C184H175FN48O2S — CID 157145734

About [4-[8-amino-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methanol;1-(1-benzothiophen-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1,3-benzoxazol-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(5-fluoro-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-inden-5-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-indol-6-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-indol-6-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(5-methyl-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine

[4-[8-amino-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methanol;1-(1-benzothiophen-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1,3-benzoxazol-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(5-fluoro-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-inden-5-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-indol-6-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-indol-6-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(5-methyl-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine (PubChem CID 157145734) has the molecular formula C184H175FN48O2S and a molecular weight of 3141.82 g/mol. Its IUPAC name is [4-[8-amino-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methanol;1-(1-benzothiophen-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1,3-benzoxazol-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(5-fluoro-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-inden-5-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-indol-6-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-indol-6-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(5-methyl-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine.

Molecular Properties

• Compound Name: [4-[8-amino-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methanol;1-(1-benzothiophen-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1,3-benzoxazol-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(5-fluoro-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-inden-5-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-indol-6-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-indol-6-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(5-methyl-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine
• PubChem CID: 157145734
• Molecular Formula: C184H175FN48O2S
• Molecular Weight: 3141.82 g/mol
• Exact Mass: 3139.48
• IUPAC Name: [4-[8-amino-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methanol;1-(1-benzothiophen-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1,3-benzoxazol-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(5-fluoro-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-inden-5-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-indol-6-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-indol-6-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(5-methyl-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine
• SMILES: Cc1ccc2[nH]c(-c3nc(C4CCC4)n4ccnc(N)c34)cc2c1.Nc1nccn2c(C3CCC(CO)CC3)nc(-c3ccc4c(c3)C=CC4)c12.Nc1nccn2c(C3CCC3)nc(-c3cc4cc(F)ccc4[nH]3)c12.Nc1nccn2c(C3CCC3)nc(-c3cc4ccccc4[nH]3)c12.Nc1nccn2c(C3CCC3)nc(-c3ccc4c(c3)C=CC4)c12.Nc1nccn2c(C3CCC3)nc(-c3ccc4cc[nH]c4c3)c12.Nc1nccn2c(C3CCC3)nc(-c3ccc4ocnc4c3)c12.Nc1nccn2c(C3CCC3)nc(-c3ccc4sccc4c3)c12.Nc1ncnn2c(C3CCC3)nc(-c3ccc4c(c3)C=CC4)c12.Nc1ncnn2c(C3CCC3)nc(-c3ccc4cc[nH]c4c3)c12
• InChI: InChI=1S/C22H24N4O.C19H19N5.C19H18N4.C18H16FN5.3C18H17N5.C18H16N4S.C17H16N6.C17H15N5O/c23-21-20-19(18-9-8-15-2-1-3-17(15)12-18)25-22(26(20)11-10-24-21)16-6-4-14(13-27)5-7-16;1-11-5-6-14-13(9-11)10-15(22-14)16-17-18(20)21-7-8-24(17)19(23-16)12-3-2-4-12;20-18-17-16(15-8-7-12-3-1-6-14(12)11-15)22-19(13-4-2-5-13)23(17)10-9-21-18;19-12-4-5-13-11(8-12)9-14(22-13)15-16-17(20)21-6-7-24(16)18(23-15)10-2-1-3-10;19-17-16-15(14-8-7-11-3-1-6-13(11)9-14)22-18(12-4-2-5-12)23(16)21-10-20-17;19-17-16-15(14-10-12-4-1-2-7-13(12)21-14)22-18(11-5-3-6-11)23(16)9-8-20-17;19-17-16-15(13-5-4-11-6-7-20-14(11)10-13)22-18(12-2-1-3-12)23(16)9-8-21-17;19-17-16-15(13-4-5-14-12(10-13)6-9-23-14)21-18(11-2-1-3-11)22(16)8-7-20-17;18-16-15-14(12-5-4-10-6-7-19-13(10)8-12)22-17(11-2-1-3-11)23(15)21-9-20-16;18-16-15-14(11-4-5-13-12(8-11)20-9-23-13)21-17(10-2-1-3-10)22(15)7-6-19-16/h1,3,8-12,14,16,27H,2,4-7,13H2,(H2,23,24);5-10,12,22H,2-4H2,1H3,(H2,20,21);1,6-11,13H,2-5H2,(H2,20,21);4-10,22H,1-3H2,(H2,20,21);1,6-10,12H,2-5H2,(H2,19,20,21);1-2,4,7-11,21H,3,5-6H2,(H2,19,20);4-10,12,20H,1-3H2,(H2,19,21);4-11H,1-3H2,(H2,19,20);4-9,11,19H,1-3H2,(H2,18,20,21);4-10H,1-3H2,(H2,18,19)
• InChIKey: AKRJAVDREZUMGD-UHFFFAOYSA-N
• XLogP: 37.17
• TPSA: 713.09 Ų
• H-Bond Donors: 16
• H-Bond Acceptors: 46
• Rotatable Bonds: 21
• Heavy Atoms: 236
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3141.82
LogP ≤ 5	37.17
H-Bond Donors ≤ 5	16
H-Bond Acceptors ≤ 10	46

Frequently Asked Questions

What is the IUPAC name of [4-[8-amino-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methanol;1-(1-benzothiophen-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1,3-benzoxazol-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(5-fluoro-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-inden-5-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-indol-6-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-indol-6-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(5-methyl-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine?

The IUPAC name of [4-[8-amino-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methanol;1-(1-benzothiophen-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1,3-benzoxazol-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(5-fluoro-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-inden-5-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-indol-6-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-indol-6-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(5-methyl-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine (CID 157145734) is [4-[8-amino-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methanol;1-(1-benzothiophen-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1,3-benzoxazol-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(5-fluoro-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-inden-5-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-indol-6-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-indol-6-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(5-methyl-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine.

What is the SMILES notation for [4-[8-amino-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methanol;1-(1-benzothiophen-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1,3-benzoxazol-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(5-fluoro-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-inden-5-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-indol-6-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-indol-6-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(5-methyl-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine?

The canonical SMILES for [4-[8-amino-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methanol;1-(1-benzothiophen-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1,3-benzoxazol-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(5-fluoro-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-inden-5-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-indol-6-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-indol-6-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(5-methyl-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine is Cc1ccc2[nH]c(-c3nc(C4CCC4)n4ccnc(N)c34)cc2c1.Nc1nccn2c(C3CCC(CO)CC3)nc(-c3ccc4c(c3)C=CC4)c12.Nc1nccn2c(C3CCC3)nc(-c3cc4cc(F)ccc4[nH]3)c12.Nc1nccn2c(C3CCC3)nc(-c3cc4ccccc4[nH]3)c12.Nc1nccn2c(C3CCC3)nc(-c3ccc4c(c3)C=CC4)c12.Nc1nccn2c(C3CCC3)nc(-c3ccc4cc[nH]c4c3)c12.Nc1nccn2c(C3CCC3)nc(-c3ccc4ocnc4c3)c12.Nc1nccn2c(C3CCC3)nc(-c3ccc4sccc4c3)c12.Nc1ncnn2c(C3CCC3)nc(-c3ccc4c(c3)C=CC4)c12.Nc1ncnn2c(C3CCC3)nc(-c3ccc4cc[nH]c4c3)c12.

What is the InChIKey of [4-[8-amino-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methanol;1-(1-benzothiophen-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1,3-benzoxazol-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(5-fluoro-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-inden-5-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-indol-6-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-indol-6-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(5-methyl-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine?

The InChIKey is AKRJAVDREZUMGD-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H24N4O.C19H19N5.C19H18N4.C18H16FN5.3C18H17N5.C18H16N4S.C17H16N6.C17H15N5O/c23-21-20-19(18-9-8-15-2-1-3-17(15)12-18)25-22(26(20)11-10-24-21)16-6-4-14(13-27)5-7-16;1-11-5-6-14-13(9-11)10-15(22-14)16-17-18(20)21-7-8-24(17)19(23-16)12-3-2-4-12;20-18-17-16(15-8-7-12-3-1-6-14(12)11-15)22-19(13-4-2-5-13)23(17)10-9-21-18;19-12-4-5-13-11(8-12)9-14(22-13)15-16-17(20)21-6-7-24(16)18(23-15)10-2-1-3-10;19-17-16-15(14-8-7-11-3-1-6-13(11)9-14)22-18(12-4-2-5-12)23(16)21-10-20-17;19-17-16-15(14-10-12-4-1-2-7-13(12)21-14)22-18(11-5-3-6-11)23(16)9-8-20-17;19-17-16-15(13-5-4-11-6-7-20-14(11)10-13)22-18(12-2-1-3-12)23(16)9-8-21-17;19-17-16-15(13-4-5-14-12(10-13)6-9-23-14)21-18(11-2-1-3-11)22(16)8-7-20-17;18-16-15-14(12-5-4-10-6-7-19-13(10)8-12)22-17(11-2-1-3-11)23(15)21-9-20-16;18-16-15-14(11-4-5-13-12(8-11)20-9-23-13)21-17(10-2-1-3-10)22(15)7-6-19-16/h1,3,8-12,14,16,27H,2,4-7,13H2,(H2,23,24);5-10,12,22H,2-4H2,1H3,(H2,20,21);1,6-11,13H,2-5H2,(H2,20,21);4-10,22H,1-3H2,(H2,20,21);1,6-10,12H,2-5H2,(H2,19,20,21);1-2,4,7-11,21H,3,5-6H2,(H2,19,20);4-10,12,20H,1-3H2,(H2,19,21);4-11H,1-3H2,(H2,19,20);4-9,11,19H,1-3H2,(H2,18,20,21);4-10H,1-3H2,(H2,18,19).

What are the key properties of [4-[8-amino-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methanol;1-(1-benzothiophen-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1,3-benzoxazol-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(5-fluoro-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-inden-5-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-indol-6-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-indol-6-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(5-methyl-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine?

[4-[8-amino-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methanol;1-(1-benzothiophen-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1,3-benzoxazol-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(5-fluoro-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-inden-5-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-indol-6-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-indol-6-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(5-methyl-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine has a molecular weight of 3141.82 g/mol, XLogP of 37.17, 21 rotatable bonds, 16 hydrogen bond donors, and 46 hydrogen bond acceptors.

Where does this data come from?

All data for [4-[8-amino-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methanol;1-(1-benzothiophen-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;1-(1,3-benzoxazol-5-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(5-fluoro-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-inden-5-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-inden-5-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine;3-cyclobutyl-1-(1H-indol-6-yl)imidazo[1,5-a]pyrazin-8-amine;7-cyclobutyl-5-(1H-indol-6-yl)imidazo[5,1-f][1,2,4]triazin-4-amine;3-cyclobutyl-1-(5-methyl-1H-indol-2-yl)imidazo[1,5-a]pyrazin-8-amine is sourced from PubChem (CID 157145734), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).